These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 25953574)

  • 1. Development of Gd(III) porphyrin-conjugated chitosan nanoparticles as contrast agents for magnetic resonance imaging.
    Jahanbin T; Sauriat-Dorizon H; Spearman P; Benderbous S; Korri-Youssoufi H
    Mater Sci Eng C Mater Biol Appl; 2015; 52():325-32. PubMed ID: 25953574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-loaded chitosan nanoparticles as magnetic resonance imaging contrast agents for the diagnosis of tumor.
    Zhang L; Liu Y; Yu D; Zhangl N
    J Biomed Nanotechnol; 2013 May; 9(5):863-9. PubMed ID: 23802417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
    Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
    Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
    Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging.
    Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y
    Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
    Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
    Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural polymeric nanoparticles as a non-invasive probe for mesenchymal stem cell labelling.
    Mohseni M; Shojaei S; Mehravi B; Mohammadi E
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):770-776. PubMed ID: 32297529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Microenvironment Relaxivity-Changeable Gd-Loaded Poly(L-lysine)/Carboxymethyl Chitosan Nanoparticles as Cancer-Recognizable Magnetic Resonance Imaging Contrast Agents.
    Jiang D; Zhang X; Yu D; Xiao Y; Wang T; Su Z; Liu Y; Zhang N
    J Biomed Nanotechnol; 2017 Mar; 13(3):243-54. PubMed ID: 29381026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.
    Ahmed A; Zhang C; Guo J; Hu Y; Jiang X
    Macromol Biosci; 2015 Aug; 15(8):1105-14. PubMed ID: 25846258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing T
    Marangoni VS; Neumann O; Henderson L; Kaffes CC; Zhang H; Zhang R; Bishnoi S; Ayala-Orozco C; Zucolotto V; Bankson JA; Nordlander P; Halas NJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6960-6965. PubMed ID: 28630340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cholic acid-based contrast enhancement agent for targeted MRI.
    Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of and study on magnetic resonance imaging performance of metal porphyrin modified by low molecular weight chitosan].
    Yu DJ; Li MZ; Huang XZ; Zhu WH; Huang Y; Zhang Q; Liu Q
    Guang Pu Xue Yu Guang Pu Fen Xi; 2013 Oct; 33(10):2736-9. PubMed ID: 24409727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging.
    Aryal S; Key J; Stigliano C; Ananta JS; Zhong M; Decuzzi P
    Biomaterials; 2013 Oct; 34(31):7725-32. PubMed ID: 23871540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment.
    Xu D; Lu ST; Li YS; Baidya A; Mei H; He Y; Wu B
    Drug Des Devel Ther; 2018; 12():3301-3309. PubMed ID: 30323562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
    Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
    ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Fe3O4/SiO2/Gd2O(CO3)2 core/shell/shell nanoparticles as T1 and T2 dual mode MRI contrast agent.
    Yang M; Gao L; Liu K; Luo C; Wang Y; Yu L; Peng H; Zhang W
    Talanta; 2015 Jan; 131():661-5. PubMed ID: 25281156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
    Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
    Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity.
    Chen KJ; Wolahan SM; Wang H; Hsu CH; Chang HW; Durazo A; Hwang LP; Garcia MA; Jiang ZK; Wu L; Lin YY; Tseng HR
    Biomaterials; 2011 Mar; 32(8):2160-5. PubMed ID: 21167594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.